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Abstract
Background: The ability of a neuron to regenerate functional connections after injury is
influenced by both its intrinsic state and also by extrinsic cues in its surroundings. Investigations of
the transcriptional changes undergone by neurons during in vivo models of injury and regeneration
have revealed many transcripts associated with these processes. Because of the complex milieu of
interactions in vivo, these results include not only expression changes directly related to
regenerative outgrowth and but also unrelated responses to surrounding cells and signals. In vitro
models of neurite outgrowth provide a means to study the intrinsic transcriptional patterns of
neurite outgrowth in the absence of extensive extrinsic cues from nearby cells and tissues.
Results: We have undertaken a genome-wide study of transcriptional activity in embryonic
superior cervical ganglia (SCG) and dorsal root ganglia (DRG) during a time course of neurite
outgrowth in vitro. Gene expression observed in these models likely includes both developmental
gene expression patterns and regenerative responses to axotomy, which occurs as the result of
tissue dissection. Comparison across both models revealed many genes with similar gene
expression patterns during neurite outgrowth. These patterns were minimally affected by exposure
to the potent inhibitory cue Semaphorin3A, indicating that this extrinsic cue does not exert major
effects at the level of nuclear transcription. We also compared our data to several published studies
of DRG and SCG gene expression in animal models of regeneration, and found the expression of
a large number of genes in common between neurite outgrowth in vitro and regeneration in vivo.
Conclusion: Many gene expression changes undergone by SCG and DRG during in vitro outgrowth
are shared between these two tissue types and in common with in vivo regeneration models. This
suggests that the genes identified in this in vitro study may represent new candidates worthy of
further study for potential roles in the therapeutic regrowth of neuronal connections.
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Neuronal development, as well as neuronal response to
injury, depend on both intrinsic programs of gene expres-
sion and on extrinsic cues from the surrounding environ-
ment. Understanding the balance between these two, and
potentially influencing it, are the focus of current strate-
gies to improve neuronal regeneration after injury [1].
That the intrinsic state of a neuron can be manipulated to
improve regeneration has been well-demonstrated in dor-
sal root ganglia (DRG) neurons, where neurite outgrowth
in response to spinal nerve injury is significantly
improved by a preceding peripheral nerve lesion [2-5].
This ability of intrinsic changes to influence neurite out-
growth has been further demonstrated by transgenic
expression of genes such as cytoskeleton-associated pro-
tein 23 (CAP23), growth associated protein 43 (GAP43),
small proline-rich repeat protein 1A (Sprr1A), and activat-
ing transcription factor 3 (Atf3) [6-10].
In addition to intrinsic effects, the extrinsic environment
also vastly influences outgrowth ability [11,12]. For exam-
ple, neurite regrowth is affected by injury-induced inhibi-
tory factors such as Semaphorins, Nogo, and myelin-
associated glycoprotein, as well as reactive microglia and
fibrous scar tissue [12-15]. Grafts of peripheral nervous
system (PNS) tissue at sites of central nervous system
(CNS) lesion can improve neurite growth across an other-
wise inhibitory scar, and much research has been focused
on distinguishing the growth-permissive and growth-
inhibitory aspects of these two [16-18].
Measuring changes in neuronal gene expression in models
of regeneration has allowed for a combinatorial readout
of both intrinsic and extrinsic factors, since many extrinsic
cues elicit intracellular signals that affect transcription
[19-26]. However the complexity of in vivo models means
that responses that causally affect a neuron's regeneration
are observed simultaneously with dispensable secondary
or tertiary effects of the environment and signaling from
other affected cells. In vitro models provide an opportu-
nity to address this, by allowing for tighter experimental
control of the extrinsic environment while still allowing
measurement of intrinsic transcriptional activity.
In the present study, we have used two in vitro model sys-
tems, those of superior cervical ganglia (SCG) and DRG,
to study intrinsic transcriptional activity during neurite
outgrowth. Explanting these tissues provides the dual con-
ditions of axotomy, which mirrors in vivo regeneration
models, and a controlled extracellular environment,
where we can observe gene expression changes during
neurite outgrowth in the absence of signaling from multi-
ple guidance factors and injury-induced signals in vivo. We
compared these effects to published data on genes associ-
ated with regeneration in vivo, and found many areas of
commonality. We also attempted to perturb these gene
expression patterns with exposure to Semaphorin 3A
(Sema3A), a potent extrinsic inhibitory cue that affects
both local growth cone morphology and also axoplasmic
transport – a means of potentially conveying signals back
to the nucleus [27,28]. These data demonstrate the appli-
cability of comparing across in vitro and in vivo models of
neurite outgrowth, and their potential for revealing genes
involved in intrinsic patterns of regeneration.
Results
Intrinsic patterns of gene expression during neurite 
outgrowth in vitro
We wished to determine the transcriptional profiles of
neurons undergoing neurite outgrowth in vitro. We were
particularly interested in finding genes whose expression
is generally associated with the process of neurite out-
growth, rather than with cell type-specific effects. Thus, in
order to avoid focusing on transcripts unique to one tissue
type versus another, we used a comparative strategy to
look for effects that were common to two tissue types and
therefore more likely to be involved in the general process
of neurite outgrowth. While these explants contain multi-
ple cell types, we felt this was preferable to the more dis-
ruptive conditions required to dissociate neurons or
obtain a pure neuron population. To this end, we moni-
tored gene expression in cultured explants from SCG and
DRG using DNA microarrays.
We initiated our studies by culturing embryonic day 13
(E13) mouse SCG in vitro and harvesting tissue for RNA
isolation at time points from 2 to 65 hours. Time points
were selected to detect both fast, short-term responses (2,
5 and 12 hours), as well as sustained, long-term changes
(24, 40, and 65 hours). Samples were hybridized to
Affymetrix MG-U74v2 A and B microarrays, with RNA
from acutely dissected explants serving as a baseline refer-
ence. In SCG, 5,097 probesets were observed to change
1.5 fold or greater over time. To test if these changes were
significantly different from the null hypothesis (no
change over time), we used a polynomial regression of the
maximum of quadratic order. This analysis revealed that
1,728 probesets were significantly changed (p ≤ 0.05) dur-
ing neurite outgrowth by SCG.
We followed these experiments with a parallel analysis of
a more heterogeneous tissue type, the DRG, which is more
frequently used than SCG for in vivo studies of neurite
regeneration. Cervical and upper thoracic DRG from E12
embryos were cultured with NGF (the same trophic sup-
port as in SCG cultures) and harvested at time points from
2 to 40 hours. Using Affymetrix MOE 430A microarrays,
4,860 probesets were observed to change 1.5 fold or more
during neurite outgrowth in cultured DRG, with 2,632
changes of p ≤ 0.05 by quadratic statistical analysis.Page 2 of 17
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growth by both these model neuron populations may rep-
resent those most relevant to neurite outgrowth or
regeneration in general. Thus, we combined the SCG and
DRG microarray data by identifying 11,268 matching
probesets from the two types of Affymetrix microarrays
used for these experiments (MG-U74v2 A and B for SCG
and MOE430A for DRG). 712 matched probesets were
changed significantly at least 1.5 fold (p ≤ 0.05). To visu-
alize these gene expression profiles, a clustering algorithm
called Hierarchical Ordered Partitioning and Collapsing
Hybrid (HOPACH) was used (Figure 1) [29]. HOPACH is
similar to traditional hierarchical clustering, but also pro-
vides statistically set cluster divisions at each sub-level
[30]. The data are visualized as a dual time-course, with
the DRG samples over time followed by the SCG samples
over time (Figure 1A). The first-level HOPACH clusters
(horizontal gray lines, Figure 1A) group genes with com-
mon regulation patterns in both DRG and SCG (e.g., up-
regulated in both or down-regulated in both), as well as
those with more divergent patterns.
We wished to determine the biological functions of these
gene clusters. The MAPPFinder function of GenMAPP was
used to test for significant localization of particular bio-
logical functions (listed as Gene Ontology (GO) terms) to
each of the main HOPACH clusters [31-34]. GO terms
over-represented in each cluster, as compared to their
presence in the whole dataset, are shown in Figure 1B (p
≤ 0.05). Significant down-regulation, by both SCG and
DRG, was found for genes involved in cell division and
nuclear metabolism (1st cluster, Figure 1). Common
upregulation (3rd cluster, Figure 1) was observed for genes
associated with extracellular matrix, basement membrane,
and cell adhesion, suggesting remodeling of the local
environment to allow axon outgrowth. Increases in both
SCG and DRG of genes involved in proteolysis and lyso-
some function echo previous observations of increases in
these gene families after neuronal injury [25,35]. Finally,
neurite outgrowth relies on the increased production of
both membrane and cytoplasmic components [36], as can
be observed in the large numbers of genes in the com-
monly upregulated group (3rd cluster, Figure 1), where
genes involved in lipid metabolism and cytoplasmic com-
ponents are localized.
In addition to looking at DRG and SCG changes together,
the data for each time course of neurite outgrowth were
clustered and annotated separately (see Additional file 1 –
Additional Figures 2 and 3). One of the unique categories
identified in DRG but not SCG is the late induction of
apoptosis-related genes. This is not surprising, since apop-
tosis is normally underway in DRG neurons of this age,
while SCG neurons undergo apoptosis in vivo at a later age
[37,38]. In addition, while most SCG neurons are NGF-
responsive at this time, DRG are more heterogeneous and
include both NGF- and neurotrophin 3-responsive neu-
rons, of which the latter may undergo cell death in these
cultures [39-42]. MAPPFinder annotation of these clusters
thus confirms previously observed differences in their
developmental programs, and demonstrates that func-
tions known to be involved in neurite outgrowth are rep-
resented in these data.
We also wanted to uncover novel biological associations
in these data. As one approach to this, we examined the
next smaller level of HOPACH clusters. Most significant
biological functions localized in these smaller clusters
were also represented in the larger main clusters, as shown
by the vertical colored bars and matching colored boxes in
the GO term list in Figure 1. However one example of
novel biological associations found at the sub-cluster level
is demonstrated by a group of genes at the bottom of Fig-
ure 1A. This sub-cluster contains twelve genes, of which
six are associated by GenMAPP with nucleic acid binding
(permuted P = 0.002): Atf3, early growth response 1
(Egr1/Krox-24/Zif-268/NGFIA), eukaryotic translation
initiation factor 2 (Eif2s2), Gm1103 (or Zbtb2), muscu-
loaponeurotic fibrosarcoma oncogene family protein F
(Maff), and c-myc intron 1 binding protein (Mibp1) (Fig-
ure 1C). The expression of these genes peaks earlier than
most other genes in cluster 3, suggesting a potential for
temporal regulation. Atf3 upregulation has been previ-
ously noted after injury, and its regeneration-promoting
ability has been recently demonstrated in vivo by Seijffers
et al (2007) [7,19,21,43]. Egr1 is a multi-functional tran-
scription regulator in both neuronal and non-neuronal
cells. In the nervous system, it is associated with plasticity
and synaptic activity, although a transient activation after
neuronal injury has been noted [44,45]. Maff has recently
been described as part of a negative downstream regula-
tory loop after activation of Egr1 [46]. Although Mibp1
has been previously found to be neuronally expressed
[47], neither Mibp1, Eif2s2, Gm1103, nor Maff have been
previously linked to regeneration. However their close
association with Atf3 and similar temporal expression
suggests them as good candidates for a role in neurite out-
growth and regeneration.
Relating gene expression patterns of growth in vitro to 
regeneration in vivo
To understand how the transcriptional patterns of neurite
outgrowth in cultured DRG and SCG relate to regenera-
tion of adult ganglia, these data were compared to several
published studies of adult DRG and SCG regeneration in
vivo. For this meta-analysis, three recently published stud-
ies with large datasets were selected, and the time point
from each study that most closely matched the other avail-
able data was used. From Costigan et al., the data included
187 unique genes significantly regulated at least 1.5 foldPage 3 of 17
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HOPACH clustering and GenMAPP annotation of genes changed in both DRG and SCG during neurite outgrowth in vitroFigure 1
HOPACH clustering and GenMAPP annotation of genes changed in both DRG and SCG during neurite out-
growth in vitro. (A) The cluster displays the averaged Affymetrix microarray data for 5 time points of DRG outgrowth (2, 5, 
12, 24, and 40 hours) and 6 time points of SCG outgrowth (same as DRG plus 65 hour endpoint), for the 712 probe sets found 
to change more than 1.5 fold (p ≤ 0.05) in both datasets. Genes annotated along the left column are those also found in two or 
more of the in vivo regeneration studies (see Figure 2). Yellow indicates increased expression or probe intensity relative to the 
acutely dissected reference pool, while blue indicates decreased expression (log2 scale). Horizontal gray bars separate the first 
level clusters, and colored vertical bars along the right indicate the next level of sub-clusters. (B) MAPPFinder annotations of 
Gene Ontology categories represented in the first-level clusters, along with number of genes found in this cluster relative to 
the total number found in all three clusters for each category (all Z-scores > 2 and permuted-p ≤ 0.05). Terms in parentheses 
show related categories that were also significant. Terms in bold have a p-value ≤ 0.05 after adjustment for multiple hypothesis 
testing. In cases where annotations for first-level clusters also appeared in MAPPFinder annotation of the next level sub-clus-
ters (with Z-scores > 2, permuted-p ≤ 0.05), those localizations to sub-clusters are indicated by an appropriately colored 
square. (C) Six nucleic-acid binding genes were detected by GenMAPP in a sub-cluster of (A) (marked by asterisk). These 
genes peak temporally earlier than most others in cluster 3. Ratio of expression change over time for these genes is color-
coded as in (A).
BMC Neuroscience 2007, 8:100 http://www.biomedcentral.com/1471-2202/8/100in lumbar DRG at three days after sciatic nerve axotomy
[21]. In Xiao et al., 88 genes were significantly regulated at
least 2 fold in lumbar DRG at two days after sciatic nerve
axotomy [23]. Finally, the data from Boeshore et al. pro-
vided 248 genes significantly regulated at least 2 fold in
SCG at two days after axotomy of the internal and external
carotid nerves [19]. A total of 78 genes are found in com-
mon among at least two of these three studies of neurite
regeneration in vivo (Figure 2A, see also Additional file 2 –
Meta-analysis table), of which 66 are found among the
probesets in our data. Of the 66 genes found in the DRG-
SCG in vitro dataset, 34 genes were also significantly
changed during in vitro outgrowth of one or both explant
types.
Our data provide an opportunity to look at the behavior
of this group of previously identified regeneration-associ-
ated genes in two common in vitro models of neurite out-
growth. At the time of dissection both DRG and SCG have
extended significant nerve projections (E12 for DRG and
E13 for SCG) [48-52]. Therefore these embryonic in vitro
culture models encompass both ongoing developmental
gene expression as well as effects of axotomy. We localized
the 34 genes commonly affected during in vivo regenera-
tion models and in vitro outgrowth models on the cluster
diagrams described above (annotated in Figure 1A and
Additional file 1 – Additional Figures 2 and 3; see also
Additional file 2 – Meta-analysis and Abbreviations
tables). The localization of these changed genes on the
cluster diagrams provides insights into which of these in
vivo regeneration-associated genes may be part of an
intrinsic outgrowth program. For instance, down-regula-
tion of the transcription factor Isl1 and up-regulation of
the catabolic enzyme lysozyme have both been previously
noted during DRG and SCG in vivo regeneration, and
these genes behave similarly during embryonic neurite
outgrowth [19,21,23,53]. This suggests that their func-
tions may be truly intrinsic to this process. However genes
such as neuropeptide Y (Npy), growth arrest and DNA
damage inducible protein 45 (Gadd45A), arginase 1
(Arg1), and protein tyrosine phosphatase 4a1, all of
which are upregulated during in vivo regeneration, are
down-regulated over time during outgrowth by embry-
onic SCG and DRG [19,21-23,53-56]. This suggests that
upregulation of these genes may not be an absolute
requirement for neurite outgrowth or regeneration. Thus
the present data not only suggests additional outgrowth-
associated genes, but may also suggest which in vivo
changes are intrinsic to neurite extension, and which may
be the result of the extrinsic environment or synaptic
interactions.
In addition to these 34 genes changed both in vivo and in
vitro, there were also 32 regeneration-associated genes
present but not changed significantly in vitro (see Addi-
Meta-analysis of genes changed during in vivo models of regener tionFi ur  2
Meta-analysis of genes changed during in vivo models 
of regeneration. (A) Venn diagram of genes affected in 
common across in vivo regeneration models. Data from three 
published studies of in vivo regeneration after peripheral 
axotomy in adult rats were compared to each other. Those 
genes found by two or more of these studies (shaded regions 
of overlap, n = 78) are also noted on the clusters found in 
Figure 1 and in Additional file 1 (Additional Figures 2 and 3). 
All genes were mapped to a common Entrez Gene ID, which 
is listed in Additional file 2 along with associated data. (B) 
Scatter plot of median intensity in both DRG and SCG for 
each unique Entrez gene found in this study. Probesets were 
collapsed to select only one unique Entrez ID per gene, so 
that genes with multiple probesets on the array would not 
skew the data. Blue, green, and yellow points highlight genes 
whose intensity of expression are respectively in the top 5%, 
2%, and 1% intersection of all DRG- and SCG-expressed 
genes. Further annotation of these highly-expressed tran-
scripts is found in Figure 3. DRG in vivo1, rat gene regulated 3 
days after sciatic nerve axotomy (n = 187) [21]. DRG in vivo2, 
rat gene regulated 2 days after sciatic nerve axotomy (n = 
88) [23]. SCG in vivo3, rat gene regulated 2 days after post-
ganglionic nerve axotomy (n = 230) [19].Page 5 of 17
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BMC Neuroscience 2007, 8:100 http://www.biomedcentral.com/1471-2202/8/100tional file 2 – Meta-analysis table). These 32 genes are gen-
erally of low intensity, with a median intensity value of
5.1 in DRG and 5.65 in SCG, as compared to a median
intensity of 8.4 in DRG or 9.1 in SCG for the 34 regenera-
tion- and in vitro outgrowth-associated genes. These 32
genes include those functioning mainly in mature neu-
rons (such as galanin and receptors for benzodiazepine,
serotonin, or glutamate) or in non-neuronal cells (such as
glial fibrillary acidic protein (GFAP) or the glial high affin-
ity glutamate transporter Slc1a3). The lack of significant
change for these transcripts in vitro is difficult to interpret,
since low intensity may reflect alternatively active repres-
sion or a low expression level in the growing cells.
The two groups of genes from the meta-analysis encom-
pass two possible patterns of gene expression in explants
undergoing outgrowth in vitro – first, the up- or down-reg-
ulation of transcripts from a starting level, and second, the
failure to up or down-regulate a given set of transcripts. A
third possibility is that genes highly expressed in develop-
ing neurons in vivo would be required and/or maintained
at a high level of expression during outgrowth in vitro.
These genes would not appear to be upregulated over
time, and would thus not be captured by our previous
analyses. Since microarray hybridization intensity usually
scales with increasing expression levels, we calculated a
median intensity value for each gene in the DRG-SCG
dataset as a relative measure of expression. The intensity
values were plotted against each other, revealing a linear
relationship (r = 0.767) (Figure 2B). Thus many genes are
expressed at similar levels in both tissues. For instance,
within the top 2% highest intensity genes, more than half
(71%) are highly expressed in both DRG and SCG.
Upon examination of the genes identified in this highest
intensity, most highly expressed group of transcripts, we
found many genes previously linked to regeneration (see
Additional file 2 – Top 5% intersection table). These
include several of the best-known regeneration associated
genes, including SCG10 (Stathmin 2), Gap43, Cap23
(also known as brain abundant membrane-attached sig-
nal protein 1, Basp1), and MARCKS [57-61]. Two other
large categories of genes include proteins involved with
ribosomal functions or cytoskeletal dynamics, both of
which are relevant to the process of neurite outgrowth. To
quantify these observations, we used MAPPFinder to
assess the over-representation of GO terms among the
most highly expressed genes (shown in Figure 3B). Figure
3A illustrates several of these functional groups and notes
which transcripts have been previously linked to regener-
ation [57-61]. Together, the meta-analysis and intensity-
analysis confirm that gene expression patterns of neurite
outgrowth in vitro incorporate many growth-competence
genes associated with neurite regeneration in vivo, as well
as pointing to potentially novel members of these groups
for further study.
Validation of transcriptional patterns associated with 
neurite outgrowth
The Affymetrix microarray experiments described thus far
identify expression changes in SCG and DRG cultures
undergoing active neurite outgrowth. To validate these
changes, both an alternative microarray platform and
quantitative real-time RT-PCR (qPCR) were used. First, we
used spotted DNA microarrays of the RIKEN 19 K release
set to measure changes in both DRG and SCG samples
(for details see Additional file 1 – Additional Methods).
These analyses revealed similar patterns of gene expres-
sion change as found by Affymetrix arrays (data not
shown). We compared the data for transcripts found on
both platforms, and of the 2,632 probesets observed to
change significantly in DRG during neurite outgrowth,
489 had representative cDNA probes represented in the
RIKEN data. This subset of genes displayed an average
Spearman correlation of 0.56 (interquartile range (IQR):
0.4, 0.7, 0.9) between the two platforms. For the 1,728
probesets changed significantly in SCG, 395 are repre-
sented in the RIKEN data, with an average Spearman cor-
relation of 0.53 (IQR: 0.26, 0.71, 0.89). The positive
correlations of these data are visually depicted on a gene-
by-gene basis in Additional file 1 – Additional Figures 2A
and 3A.
We also selected several genes for individual validation
using qPCR with dual-labeled fluorescent hydrolysis
probes. These genes were selected to include a wide range
of fold changes detected by microarray (e.g. 1.8-fold
increase for Gli2 in DRG, versus over 100-fold increase for
crystallin alpha B in DRG), as well as to include transcripts
potentially affected by the extrinsic cue Sema3A (see
below). The expression changes of all eight DRG genes
selected for significant changes by microarray analysis
were validated by qPCR (Table 1). Similarly, 4 out of 6
genes observed by microarray analysis to change signifi-
cantly over time in SCG were validated by qPCR (Table 2).
Figure 4 illustrates the time course of gene expression
change in DRG (Figure 4A) and in SCG (Figure 4B) for
those genes with significant change over time by both
microarray and qPCR. Thus, we believe that many if not
most of the changes identified by microarray analysis
indeed reflect real changes in mRNA abundance in the
two explant culture systems.
Limited effects of Semaphorin 3A on transcription
Axon growth cones can exhibit dramatic changes in their
morphologies, direction, and rate of growth in response
to extrinsic protein cues encountered in the environment
[62,63]. Semaphorin 3A (Sema3A) is one such diffusible
axon guidance cue with potent repellent activity for bothPage 6 of 17
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Gene ontology categories for the genes most highly expressed in both SCG and DRGFigure 3
Gene ontology categories for the genes most highly expressed in both SCG and DRG. Major gene ontology cate-
gories for the genes most highly expressed in both SCG and DRG are colored by probe intensity (same color scheme as Figure 
2B), including where available their cellular localization and prior evidence of association with regeneration (triangles). (A) Dia-
gram of a neuron with localization of function for 82 of the 325 genes in the top 5% intersection of genes most highly 
expressed in both DRG and SCG. A triangle to the left of a transcript indicates a gene previously linked to regeneration (see 
references in text), and triangle to the right of a transcript indicates that another subunit or isoform of this gene was previously 
linked to regeneration. Gene names are listed in Additional file 2. (B) Lists the major Gene Ontology terms found by MAPP-
Finder for the top 2% intersection of both DRG and SCG expression levels. To the right of each GO term is the number of 
genes found in this group relative to the rest of the dataset. All observations had a Z-score > 2 and permuted-p ≤ 0.05. Terms 
in parentheses show related categories that were also significant, and those in bold had a p-value ≤ 0.05 after adjustment for 
multiple hypothesis testing.
BMC Neuroscience 2007, 8:100 http://www.biomedcentral.com/1471-2202/8/100SCG and DRG neurons [63-65]. In addition, Sema3A has
been demonstrated to affect local protein translation and
axoplasmic transport, suggesting to us the possibility that
Sema3A may interact with signaling cascades, including
those that regulate gene transcription in the nucleus
[27,66,67]. As an approach to determining whether expo-
sure to an extrinsic cue such as Sema3A can elicit changes
in gene expression, we cultured explants in the presence or
absence of a heterologous source of Sema3A for varying
amounts of time, and carried out microarray analyses as
described above.
In spite of a robust effect by Sema3A on the morphology
of neurite outgrowth in both culture systems (see Addi-
tional file 1 – Additional Figure 1), we found relatively
few genes showing robust differences in gene expression
in explants cultured in the presence or absence of
Sema3A. As a quantitative measure, a gene was operation-
ally defined as Sema3A-affected if it showed a 1.5 fold or
greater difference between control and Sema3A-treated
samples at any one time point, as well as a p-value ≤ 0.05
by quadratic analysis. Using these criteria, we observed 74
probesets affected by Sema3A in DRG, and 249 probesets
affected by Sema3A in SCG (see Additional file 2 –
Sema3A effects table). The magnitude of changes
observed was subtle–for DRG probesets the median fold
difference between control and Sema3A treated samples
was 1.72 fold (IQR: 1.6, 1.72, 1.96; maximum 3.5), and
for SCG probesets it was 1.76 fold (IQR: 1.6, 1.76, 2.04;
maximum 4.68). With just one exception, however, none
of the genes selected for validation by qPCR were shown
to be regulated by Sema3A in either DRG or SCG (see
below).
Taking these data at face value, it is difficult to confirm or
rule out the possibility that Sema3A induces any mean-
ingful changes at the transcriptional level. We therefore
reasoned that if Sema3A causes a significant and biologi-
cally-relevant effect on transcription, the most likely genes
affected might encode proteins either directly in the sem-
aphorin signaling pathway or otherwise known to be
involved in cell signaling or cytoskeletal dynamics. To test
this idea, a candidate list was compiled of genes previ-
ously described to be downstream of Sema3A or related
guidance cues [64,68-70]. GenMAPP was used to analyze
this pathway for effects found during neurite outgrowth or
exposure to Sema3A, and this revealed many more genes
affected by neurite outgrowth than by Sema3A (Figure 5).
Table 1: Validation using quantitative real-time PCR (qPCR) of genes found to change significantly in DRG by microarray.
Gene Gene Title Max. fold change by microarray§ Max. fold change by qPCR p-value
Cntn3 Contactin 3 2.6 11.0 0.007
Col18 Procollagen, type XVIII, alpha 1 4.3 8.1 0.0003
Cryab* Crystallin, alpha B 123.0 42.5 <.0001
Fdps Farnesyl diphosphate synthetase 2.4 2.0 <.0001
Gli2* GLI-Kruppel family member GLI2 1.8 2.4 0.03**
Sparc Secreted acidic cysteine rich glycoprotein 4.8 6.5 <.0001
Timp3* Tissue inhibitor of metalloproteinase 3 2.6 3.6 0.003
Tubb3 Tubulin, beta 3 1.6 2.6 0.0002
p-value indicates significance of qPCR data for a quadratic model of change over time.
* Selection of these genes included probesets not part of the matched DRG-SCG dataset, as an additional screen for genes missed by these filters.
** Significance for this gene is for a linear model of change over time; this gene does not fit a quadratic model.
§ Changes observed by microarray were statistically significant (quadratic model; p ≤ 0.05).
Table 2: Validation using quantitative real-time PCR (qPCR) of genes found to change significantly in SCG by microarray.
Gene Gene Title Max. fold change by microarray§ Max. fold change by qPCR p-value
Col18 Procollagen, type XVIII, alpha 1 2.0 2.3 0.59
Fdps Farnesyl diphosphate synthetase 1.8 2.3 0.05
Itga4 Integrin alpha 4 2.8 5.3 0.05**
L05* RIKEN cDNA 1110035L05 gene 6.8 5.4 0.02
Ptprm Receptor protein tyrosine phosphatase M 2.7 5.6 0.008
Timp3* Tissue inhibitor of metalloproteinase 3 2.1 2.1 0.25
p-value indicates significance of qPCR data for a quadratic model of change over time. Italicized p-values for two genes indicate lack of statistical 
significance.
* Selection of these genes included probesets not part of the matched DRG-SCG dataset, as an additional screen for genes missed by these filters.
** Significance for this gene is for a linear model of change over time; this gene does not fit a quadratic model.
§ Changes observed by microarray were statistically significant (quadratic model; p ≤ 0.05).Page 8 of 17
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of Sema3A-affected genes in this group relative to their
representation in the whole dataset. The only two genes
with potential Sema3A effects on this MAPP (Semaphorin
4D and Tubulin gamma 1) showed less than a 2-fold max-
imum difference between control and Sema3A-treated
samples. We also analyzed a list of 360 guidance-related
signaling molecules, including gene families and recep-
tors for ephrins, netrins, transforming growth factor betas,
neurotrophins, small GTP associated proteins, cadherins
and other extracellular matrix molecules, protein kinases,
and many other pathways [63,71-73]. Similar to Figure 5,
GenMAPP analysis of this pathway revealed no significant
enrichment of genes affected by Sema3A exposure (data
not shown).
Quantitative PCR analysis was used to further investigate
several potential Sema3A-affected transcripts found by
microarray analysis. Measurement of a 2-fold change is
near the detection limit of qPCR, so it is not surprising
that for most genes analyzed, qPCR either did not reveal a
substantial effect of Sema3A or else the effect was not sta-
tistically significant (Table 3 – DRG and Table 4 – SCG,
see also Additional file 1 – Additional Figures 4 and 5).
The only gene for which a statistically significant Sema3A
effect was observed by qPCR–of a maximum 1.7 fold
change–was tubulin beta 3 (Tubb3) in DRG (Table 3).
Since Tubb3 is a cytoskeletal component, its upregulation
could indicate an effect of extrinsic cue signaling on the
neuronal cytoskeleton. The lack of validation for the
majority of Sema3A-affected genes indicates that changes
observed by microarray are either within the level of
noise, or that very subtle effects are masked by technical
Comparison of gene expression data by microarray analysis and qPCRFigure 4
Comparison of gene expression data by microarray analysis and qPCR. Time course of gene expression change in 
DRG (A) and in SCG (B) for genes with statistically significant change by both microarray and qPCR (p ≤ 0.05; see Tables 1–2 
for gene names and details). Solid lines plot the quadratic fit of Affymetrix intensity values over time, while the dashed line rep-
resents the quadratic fit of the qPCR log ratios. All data is expressed in a log2 scale. qPCR data are normalized to a common 
reference gene (Wdr4; see Methods for details) and plotted relative to the 2 hour starting point.Page 9 of 17
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confirmed that there are no large-scale effects of Sema3A
at the transcriptional level. Taken together, our results
suggest that effects of the extrinsic cue Sema3A on neurite
outgrowth in SCG and DRG are not manifested at the
transcriptional level, but rather are focused on biochemi-
cal changes at the level of receptors and other signaling
molecules localized to axonal or cytoplasmic compart-
ments of the cell.
Discussion
Comparing across in vitro models
We assessed the gene expression patterns of neurite out-
growth for two different neuronal populations over a
wide range of time points. This comparative approach is
advantageous because it reveals commonalities across
divergent cell types of the peripheral nervous system. As
expected for tissues serving different biological functions
and isolated from different chronological ages, there are
differences in gene expression between these two explant
types. However of the genes that are actively engaged by
neurite outgrowth in both SCG and DRG, there are more
similarities in direction of change than divergences (see
Figure 1 for illustration). These commonalities in gene
expression are likely to be related to the similar activity
undergone by these explants over time. The observation
that so many genes are changing similarly in both neuro-
nal tissue types suggests that these effects may be relevant
to other neurons as well. The cluster of transcriptional reg-
Gene expression changes observed in Sema3A signaling pathwayFigur  5
Gene expression changes observed in Sema3A signaling pathway. Model of Sema3A signaling pathway, colored by 
GenMAPP to depict under-representation of genes changed during Sema3A exposure, as compared to the number changed 
during neurite outgrowth in vitro. Criteria for changed genes are the same as for the microarray analysis. Genes on the MAPP 
include both validated interaction partners from the literature as well as their homologs. Gene names are listed in Additional 
file 2.Page 10 of 17
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group of genes for future investigation.
Sema3A does not elicit significant transcriptional changes
Previous data on the growth-cone collapsing effects of
Sema3A, as well as its ability to affect axoplasmic trans-
port, suggested to us that Sema3A could act at multiple
levels, with local effects on growth cone morphology as
well as downstream effects on the nucleus [27,28,63-67].
Other developmental guidance cues such as bone mor-
phogenetic proteins, Sonic hedgehog, and wingless-
related proteins have both transcriptional and local effects
[71,74-86]. To address whether the gene expression pat-
terns of neurite outgrowth or regeneration were affected
by extrinsic factors such as Sema3A, we conducted parallel
experiments with and without Sema3A in the culture envi-
ronment. For this extrinsic cue, minimal changes in the
number and magnitude of gene expression were observed,
despite careful scrutiny of both individual genes and a sys-
tematic search for pathway-level effects. We were unable
to experimentally validate any of the Sema3A-related
changes observed by microarray. Although we cannot rule
out the possibility that we missed other effects due to
experimental limitations (e.g. changes in a gene not on
our microarrays, at another time point, or below the level
of detection), our results nonetheless suggest that the
inhibitory effects of Sema3A at sites of injury and regener-
ation in vivo are mediated locally and not via transcrip-
tional changes in the responding cells.
Parallels and insights for in vivo regeneration
To discern potentially important candidates within the
genes commonly affected during outgrowth by SCG and
DRG, we compared our data to several previously pub-
lished studies of neurite regeneration in vivo. This analysis
revealed commonalities between neurite outgrowth in
vitro and regeneration in vivo, and it also revealed differ-
ences between those two. The genes affected in both cases
are logically the ones that are most likely to be involved in
both processes. Among the differences, it is expected that
some transcripts expressed and affected in adult models of
regeneration are particular to mature neurons with func-
tional synaptic connections, and that others are due to
interactions with the inflammatory and inhibitory extra-
cellular environment after injury. Our data facilitates the
interpretation of in vivo data because it provides an oppor-
tunity to focus on genes involved in growth competence,
Table 3: Quantitative real-time PCR (qPCR) does not support Sema3A-induced changes in DRG observed by microarray.
Gene Gene Title Max. difference by microarray§ Max. difference by qPCR p-value
Cntn3 Contactin 3 2.1 2.6 0.34
Col18 Procollagen, type XVIII, alpha 1 1.6 2.5 0.38
Fdps Farnesyl diphosphate synthetase 1.7 1.4 0.18
Gli2* GLI-Kruppel family member GLI2 1.5 1.8 0.66
Tubb3 Tubulin, beta 3 1.3† 1.7 0.01
p-value indicates significance of qPCR data for a quadratic model of change over time. Italicized p-values indicate lack of statistical significance.
* Selection of these genes included probesets not part of the matched DRG-SCG dataset, as an additional screen for genes missed by these filters.
§ Mock-Sema3A differences observed by microarray were statistically significant (quadratic model; p ≤ 0.05).
† By microarray analysis, the mock-Sema3A differences observed for Tubb3 were not statistically significant.
Table 4: Quantitative real-time PCR (qPCR) does not support Sema3A-induced changes in SCG observed by microarray.
Gene Gene Title Max. difference by microarray§ Max. difference by qPCR p-value
Col18 Procollagen, type XVIII, alpha 1 2.7 2.5 0.66
Cryab* Crystallin, alpha B 2.5 2.2 0.21
Fdps Farnesyl diphosphate synthetase 2.0 2.3 0.22
L05* RIKEN cDNA 1110035L05 gene 4.3 1.5 0.82
Lmo4* LIM domain only 4 2.1 1.6 0.26
Ptprm Receptor protein tyrosine phosphatase M 2.7 2.8 0.27
Rce1 Ras and a-factor-converting enzyme 1 homolog 1.4 1.3 0.77
Timp3* Tissue inhibitor of metalloproteinase 3 1.7 2.6 0.18
Unc119 unc-119 homolog 1.8 1.3 0.95
Uty* Ubiquitously transcribed gene, Y chromosome 3.4 2.6 0.33
Italicized p-values indicates lack of statistical significance of qPCR data for a quadratic model of change over time.
* Selection of these genes included probesets not part of the matched DRG-SCG dataset, as an additional screen for genes missed by these filters.
§ Mock-Sema3A differences observed by microarray were statistically significant (quadratic model; p ≤ 0.05).Page 11 of 17
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the extracellular environment of injury.
The differences observed between gene expression pat-
terns of in vivo regeneration and in vitro outgrowth fall
into two main categories. First, there are genes that are
present on the array platforms used, but that have a low
intensity signal that does not appear to change over time.
Examples of this group included galanin, GFAP, and
receptors for benzodiazepine, serotonin, or glutamate.
Interpretation of this group is difficult, because a failure to
observe a strong signal may indicate either poor signal
detection by the array probes, or may indicate meaningful
transcript absence or repression in these cultures.
A second category of differences between in vivo regenera-
tion and in vitro outgrowth yields more insights. In this
group of regeneration-associated genes, the transcripts are
observed to change during in vitro outgrowth, but the
directionality of change is different. For instance, genes
that are commonly upregulated in regeneration models
but that are down-regulated during in vitro outgrowth
include arginase 1, Npy, and Gadd45A [10,19,21-
23,55,56]. The observation that these transcripts change
over time in our cultures indicates that their expression is
being regulated in these models, and it also suggests that
their upregulation (as observed after adult injury in vivo)
is not required for neurite regrowth by DRG or SCG neu-
rons in vitro. Since our models use an extrinsically control-
led in vitro environment, these observations suggest that
the changes observed in these transcripts after injury in
vivo may have more to do with responses to inhibitory
aspects of the in vivo environment or to interactions with
other cell types in the regenerating areas, rather than with
neurite outgrowth.
Finally, the process of extending neurites, which is com-
mon to both regeneration in vivo and outgrowth in vitro,
suggests that there may be commonalities in the gene
expression programs involved. This was confirmed in part
by our meta-analysis comparison of several regeneration
models in vivo to the genes changed during outgrowth in
vitro. Similar up- or down-regulation was observed for
genes including lysozyme, secretogranin 2, and the tran-
scription factors 1sl1 and Atf3. Additional commonalities
were revealed by a comparison of the genes most highly
expressed in both explant models (Figure 2B, see also
Additional file 2). As described earlier, embryonic neu-
rons are already growth competent in their gene expres-
sion patterns, and thus may already express certain
regeneration-associated genes at the time of dissection. A
number of the genes most highly expressed in both
explant types, such as GAP43, CAP23/BASP1, and SCG10,
as well as others listed above, are well documented for
their roles in regeneration [57-61]. This group of genes
that are highly expressed and maintained in these embry-
onic explants may thus be a window into potential regen-
eration-associated genes. These candidates may be ideal
for further investigation as regeneration-promoting genes,
for instance by testing their ability to stimulate neurite
outgrowth of adult neurons as was demonstrated for
GAP43 and CAP23/BASP1 [8,9].
Conclusion
By investigating intrinsic transcriptional activity in DRG
and SCG as two distinct in vitro models of neurite out-
growth, we have demonstrated commonalities in gene
expression relevant to this process. In addition, through a
meta-analysis comparison of these results to several large-
scale studies of gene expression during regeneration in
vivo, we have discerned that many transcripts affected in
vivo are also highly expressed or changed during out-
growth in vitro. Together these results demonstrate the
usefulness of our in vitro models in identifying programs
of gene expression intrinsic to regenerating neurons. We
also found that despite its potent effects as an inhibitory
extrinsic cue and potential for retrograde signaling,
Sema3A does not appear to significantly affect the intrin-
sic transcriptional activities involved in neurite out-
growth. Thus, the robust effects of semaphorin signaling
on axon growth cone guidance are most likely restricted to
local mechanisms not involving changes in gene expres-
sion in the nucleus. Our analyses present several groups of
genes relevant for future testing of potential roles in neur-
ite outgrowth or regeneration.
Methods
Cell culture
For each culture, embryonic explants were dissected from
two litters of outbred CD1 mice of either embryonic day
13 (E13) for SCG or E12 for DRG. Collagen drop cultures
were as per published methods [87,88], using either com-
mercial rat tail collagen (BD Biosciences, San Jose, CA) or
rat tail collagen prepared as per Guthrie and Lumsden
[89]. After dissection, two to four explants were embed-
ded in a collagen sandwich with an aggregate of Cos7
cells. Culture medium for SCG consisted of D-MEM/F-12
medium with 100 U/ml penicillin/streptomycin (P/S), 2
mM L-Glutamine (all Invitrogen, Carlsbad, CA), 1 mg/ml
bovine albumin, and 25 ng/ml of NGF-7S (both Sigma,
St. Louis, MO). Culture medium for DRG consisted of 1:1
F-12 and Opti-MEM I, 0.5% heat-inactivated horse serum,
2 mM GlutaMAX, 100 U/ml P/S, 40 mM glucose, and 25
ng/ml NGF.
The Cos7 cells were either mock-transfected or transiently
transfected with 5 µg Sema3A plasmid [90], using Lipo-
fectamine 2000 (Invitrogen) as per manufacturer's
instructions. Cells were aggregated by hanging drop [91].
Semaphorin expression was confirmed by observation ofPage 12 of 17
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for each transfection.
RNA isolation & amplification
A reference pool for microarray comparisons was created
by dissecting explants as above, and transferring tissues to
Trizol RNA isolation reagent (Invitrogen) without cultur-
ing. For SCG, 42 ganglia (from four litters) were collected
into four samples. For DRG, 94 ganglia (from three litters)
were collected into six samples. RNA was isolated from
these samples and quantitated as below.
Cultured DRG or SCG were harvested into Trizol at 2, 5,
12, 24, 40, and 65 hours (final time point for SCG only).
RNA was isolated as per Invitrogen protocol, treated with
RNase-free DNase (Promega, Madison, WI), cleaned via
Zymo-RNA column (ZYMO Research, Orange, CA), and
quantitated by Ribogreen assay (Molecular Probes/Invit-
rogen). For DRG samples, all five time points of each rep-
licate were collected consecutively from one culture setup,
making them continuous replicates. SCG sample tissue
was more limited, and therefore the microarray replicates
are discontinuous, composed of intermingled time points
from multiple culture setups. For the Taqman analysis
where it was feasible to use less RNA, two new SCG repli-
cates were collected as consecutive replicates. Two biolog-
ical replicates for each tissue type were collected for
hybridization to Affymetrix arrays. One of these and two
additional biological replicates were used for quantitative
RT-PCR analysis.
For each microarray sample, 50–500 ng of total RNA was
amplified using a modified Eberwine procedure [92,93].
200 ng of T7-oligo dT primer was added to each (AAAT-
TAATACGACTCACTATAGGGAGACCACA(T)21)). A 20
µl reverse transcription reaction was carried out for each
sample using Superscript III (SSIII; Invitrogen) as per
manufacturer's protocol, with reaction time extended to
16 hours. Second strand cDNA synthesis utilized DNA
ligase, DNA polymerase I holoenzyme (both New Eng-
land Biolabs, Ipswich, MA), dNTPs, and second strand
buffer (Invitrogen) for 2–6 hours at 16 degrees C. cDNA
was isolated by phenol chloroform extraction and precip-
itated. cRNA was produced from cDNA with an Ambion
T7 Megascript kit, and collected via Qiagen RNeasy col-
umn. RNA was quantitated by spectrophotometer and gel
electrophoresis. This cRNA was used directly for cDNA
labeling for spotted microarrays (see Additional file 1), or
processed through a second round amplification for
Affymetrix arrays.
Second round amplification followed the Affymetrix
Small-Sample Target Labeling Assay Version II from step 6
onward. Biotin-labeled cRNA was made using the BioAr-
ray High Yield RNA Transcript Labeling kit (Enzo Diag-
nostics, Farmingdale, NY) and eluted by RNeasy column.
cRNA was fragmented according to Affymetrix protocol.
All SCG samples were hybridized to Affymetrix MG-
U74v2 A and B arrays, and DRG samples were hybridized
to MOE430A arrays. All hybridizations were performed
via Affymetrix protocols at the Stanford Protein and
Nucleic Acid Biotechnology Facility.
Image analysis and normalization
Affymetrix array hybridization files (.cel, .exp, and .dat)
were uploaded to Genetraffic Uno (Iobion, La Jolla, CA).
Since SCG and DRG samples used two different series of
Affymetrix arrays, the data for each was extracted sepa-
rately. gcrma (version 1.1) was used to extract data [94-
96]. To balance the median array intensity between array
platforms, a constant value of 1.83 was added to the
logged intensity values for the SCG (MG-U74v2) arrays.
All files were quality assessed with the Affy and AffyExten-
sions packages for Bioconductor in R [97], and no chips
were excluded for quality reasons. Based on Affymetrix
probeset descriptions and the disproportionate number
of low-intensity probesets in these categories, probesets
annotated as incomplete (i), rules dropped (r), or cross-
hybridizing (x) were excluded. Data for each group of
arrays was baselined to the appropriate (SCG or DRG)
acutely-dissected reference pool. This facilitated compari-
son between Affymetrix platforms as well as to spotted
microarray data.
The Affymetrix same-species best-match comparison
spreadsheet was used to match probe sets between plat-
forms used for SCG and DRG hybridizations. Due to
redundancies in the older array design, multiple probe
sets on the U74v2 arrays have the same best match in the
430A design. For these cases, the Affymetrix probe
descriptions were used to determine a single best match,
by selecting if possible the probeset match without any
annotation qualifier, followed in decreasing preference
those with g, f, or s annotations. The final dataset included
11,268 probesets matched across platforms; (see Addi-
tional file 3) these were used for all further analysis.
Statistical analysis
gcrma-normalized data from SCG and DRG were ana-
lyzed separately to determine if changes in gene expres-
sion over time were statistically significant. The limma
package in R was used to test if changes in gene expression
over time fit a quadratic or linear model [98]. Data was
used for clustering and further analysis if the p value of a
moderated F statistic for either model was ≤ 0.05, and the
maximum fold change over time (between any two time
points) was at least 1.5 [99]. A false discovery rate (FDR)
test was run as well, but results of the FDR were not used
in filtering data for clustering or further analysis. To ana-
lyze effects of Sema3A, a quadratic model testing for thePage 13 of 17
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outgrowth, a one-arm model was used. For analysis of
Sema3A effects, a two-arm model was used to include the
effect of treatment. In the DRG data, a replicate variable
was also included, because the samples were biologically
continuous. Regression analysis, including both quadratic
and linear effects, was used to test the significance of
changes over time and with Sema3A treatment in the
qPCR data, after data extraction as described below.
Clustering, annotation, and visualization
Microarray data were clustered using the clustering algo-
rithm Hierarchical Ordered Partitioning and Collapsing
Hybrid (HOPACH) [29], using the cosine angle metric
(uncentered correlation). Clusters were visualized in Java
Treeview 1.0.4 after sorting by the HOPACH final order.
Visualization of the time course of expression for individ-
ual genes was done using a plotting function in R.
To annotate the biological functions of HOPACH clusters,
we used Gene Map Annotator and Pathway Profiler (Gen-
MAPP) [31,32]. For this purpose, the main order clusters
(called sub-clusters here) provided by HOPACH were
used, rather than the final-order clusters that are essen-
tially unique for every gene. Each HOPACH cluster list
was used to create a gene expression database in Gen-
MAPP, with first or second level HOPACH cluster num-
bers as filter criteria (see for example Additional file 4).
MAPPFinder was used to search for over-representation of
Gene Ontology (GO) terms [33,34] in each cluster. Signif-
icant biological associations were indicated if three or
more genes in a given GO term were changed, with a per-
muted p value ≤ 0.05. Instances where the adjusted p
value (adjusted for multiple hypothesis testing) were also
less than 0.05 are noted.
Matching to published data on in vivo regeneration models
From Costigan et al. we extracted 187 unique genes signif-
icantly regulated at least 1.5 fold in DRG, at three days
after sciatic nerve axotomy [21]. Changes were analyzed in
L4 and L5 (lumbar) DRG on the side ipsilateral to the
injury, and compared to uninjured DRG from the oppo-
site side. Hybridization was done using Affymetrix Rat
U34A arrays.
From Xiao et al. we extracted 88 unique genes significantly
regulated at least 2 fold in DRG, at two days after sciatic
nerve axotomy [23]. Changes were analyzed in L4 and L5
DRG of lesioned animals versus non-lesioned animals.
Hybridization was done using cDNA array membranes of
their own production, as well as CLONTECH Atlas arrays.
From Boeshore et al. we extracted 248 unique genes sig-
nificantly regulated at least 2 fold in SCG, at two days after
axotomy of the internal and external carotid nerves [19].
Changes were analyzed in SCGs of lesioned animals ver-
sus sham-operated animals. Hybridization was done
using Affymetrix Rat U34A arrays.
Accession numbers for Xiao et al. were annotated using
Stanford SOURCE to provide an Entrez Gene ID [100].
Entrez Gene IDs for the other studies were extracted from
Affymetrix Rat U34A annotations. Duplicate probeset-
Entrez Gene matches and probesets with no Entrez Gene
ID were excluded. Mouse Entrez Gene IDs for our data
came from Affymetrix MOE430 annotation. NCBI's
Homologene database was used to match rat and mouse
orthologs. A Matlab script by Jeremy Heil was used for
proportional Venn diagrams.
Real-time RT-PCR validation
For each gene of interest, sequence data was compared
from NCBI's Unigene, Entrez Gene (formerly Locuslink)
resources, and Ensembl [101,102]. Whenever possible,
primer-probe pairs were designed to span an intron of
1500 or more base pairs. Primers and Taqman (Applied
Biosystems, Foster City, CA) probes were selected using
Primer Express 2.0.0 (Applied Biosystems) and DSGene
1.5 (Accelrys, San Diego, CA). The average amplicon size
was 100 base pairs. Primer and probe sequences are listed
in Additional file 2, along with the NCBI Refseq for each
gene.
Unamplified total RNA was used for quantitative real-
time RT-PCR (qPCR) validation, as per Applied Biosys-
tems protocols. Two of the three biological replicates were
independent of those used for the Affymetrix arrays.
Briefly, 50 ng of total RNA was primed with random hex-
amers and reverse transcribed with SSIII as above. Each
reaction was aliquotted and a 1/20 dilution used as a tem-
plate for qPCR. qPCR used Platinum Taq (Invitrogen)
with recommended buffer and dNTP concentrations, and
were run in an MJ Opticon Monitor.
Expression was normalized by the comparative threshold
cycle method [103] using one of two reference genes,
Stathmin 2 (Stmn2/SCG10) or WD repeat domain 4
(Wdr4). For each sample, the threshold cycle of detection
was normalized to a parallel loading control of the refer-
ence gene. This was then calibrated to the 2 hour time
point, which was set to zero. All time points for a given
replicate were handled in parallel.
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